This pre-conference event offers 6.0 contact hours and features hands-on training in office skills for primary care and point-of-care ultrasound for acute care. Led by Dr. John Russell, DNP, APRN, FNP-BC, AGACNP-BC, CCRN, RNFA.
Join us for a live webinar designed to support oncology clinicians in navigating the evolving treatment landscape of extensive-stage small cell lung cancer (ES-SCLC).
Now in its 26th year, the Midwest Conference is the longest-running APRN event in the region. It offers two immersive days of high-impact learning, real-world clinical updates, and professional development designed specifically for advanced practice.
Join the experts from Allina Health Minneapolis Heart Institute for dinner, dialogue and discovery at the 2025 Cardiovascular Symposiums. These events will explore the latest advances in cardiovascular care.
Sjögren's disease (SjD) has been viewed as a condition with few symptoms beyond dry eyes and dry mouth. Recently, however, advancements have led to a heightened awareness of the systemic consequences and quality of life impacting this condition.
Join this dynamic webinar led by breast cancer experts to gain valuable insights into evolving clinical trial evidence, adverse event management, and real-world implications.
Through real-world case discussions and interactive polling, you'll gain practical strategies to apply the latest evidence for biomarker testing in head and neck squamous cell carcinoma (HNSCC) and nasopharyngeal carcinoma (NPC).
The latest Hospital Medicine CME updates for nurse practitioners, physician assistants and other healthcare professionals. Taught LIVE by practicing physicians. Relevant, up-to-date studies. Live Stream available. Save $100 with discount code: ENP100
In collaboration with American College of Surgeons-The APP Trauma Course is tailored to APPs new to trauma. It equips NPs & PAs with essential trauma knowledge and hands-on skills. Gain confidence, improve outcomes, and improve your skills! Cost $550
Join us for a dynamic, live webinar where two leading GI oncology experts will break down the latest advancements in biomarker-based, first-line treatment strategies for upper gastrointestinal (GI) cancers.
